CIBC World Market’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-38,204
Closed -$1.64M 1586
2026
Q1
$1.64M Sell
38,204
-700
-2% -$30.1K ﹤0.01% 802
2025
Q4
$1.71M Buy
38,904
+31,985
+462% +$1.32M ﹤0.01% 810
2025
Q3
$286K Sell
6,919
-9,747
-58% -$392K ﹤0.01% 1255
2025
Q2
$735K Buy
16,666
+8,465
+103% +$338K ﹤0.01% 949
2025
Q1
$303K Sell
8,201
-243
-3% -$8.66K ﹤0.01% 1148
2024
Q4
$281K Buy
+8,444
New +$274K ﹤0.01% 1198
2016
Q4
Sell
-118,934
Closed -$1.52M 1088
2016
Q3
$1.52M Buy
+118,934
New +$1.29M 0.01% 423

Other funds holding EXEL

CIBC World Market's EXEL Position: Q2 2026 in Review

CIBC World Market sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 38,204 shares — an estimated $1.64M sold.

CIBC World Market first reported a position in EXEL in Q3 2016 and held it in 7 quarters. The position peaked at $1.71M in Q4 2025. 759 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • CIBC World Market reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • CIBC World Market sold 38,204 Exelixis shares in Q2 2026, an estimated $1.64M.
  • CIBC World Market first reported a position in Exelixis in Q3 2016 and held it in 7 quarters.
  • CIBC World Market's Exelixis position peaked at $1.71M in Q4 2025.
  • 759 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.